Analysis indicated that the primary tumors and metastatic tumors had a significantly lower ratio of CD8+ to Tregs than in normal bowel tissue, whereas there was a significantly lower ratio of CD4+ to Tregs than in blood. This evidence concerns the gene CD8A and metastatic neoplasm.